Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 119.5B | 111.0B | 106.8B |
Cost of revenue | — | 73.1B | 67.7B | 65.9B |
Gross profit | — | 46.3B | 43.4B | 40.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 11.5B | 11.3B | 13.1B |
Operating income | — | 22.3B | 19.6B | 16.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 10.5B | 10.1B | 9.6B | 9.0B |
Other income expense | — | — | — | — |
Pretax income | — | 11.3B | 10.8B | 7.7B |
Tax provision | — | 3.1B | 3.1B | 2.1B |
Net income | — | 8.2B | 7.7B | 5.5B |
Basic EPS | — | 2.6 | 2.4 | 1.7 |
Diluted EPS | — | 2.6 | 2.4 | 1.7 |
Basic average shares | — | 2.9B | 2.9B | 2.9B |
Diluted average shares | — | 2.9B | 2.9B | 2.9B |
EBITDA | — | 25.7B | 23.3B | 19.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -577.5M | -609.1M | -415M |
Preferred stock dividends | — | 0 | 0 | 0 |